Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells

Gerrit Jansen(Amsterdam University Medical Centers), Godefridus J. Peters(Amsterdam University Medical Centers)

Cancer Drug Resistance

January 1, 2023

10.20517/cdr.2023.20

Cited by 9

Related Papers

Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors

|British Journal of Cancer|2011|72

The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment

|Expert Opinion on Investigational Drugs|2020|66

Molecular pathways involved in the synergistic interaction of the PKCβ inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells

|British Journal of Cancer|2008|45

Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR

|Oncotarget|2015|31

Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines

|Cancer Science|2009|30